{"name":"Enterin Inc.","slug":"enterin-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxPT0NCdG44R2tfcWJkaFBWaXlJTGhNbC0xQW9xSW9mQXJHcWh3X09zeERjbE4zVG4tSnhMRGVIaUt0M1lPa1ZxdEI1ZlBHT1NKbU5rOXM3QjVESnNFcUR4eXZsRzhFVGwwSk1md01CMEZORGhjV1FTOVotRVhFcUU4eUV0Z2RKUEdtdGJYaXZXeUdubzVJbjBaMEt3TkkwQTFuUnZCZGVCeThkXzFQNjc3NEhYUVUzSnlDWENtSVpvNzA2LW9HYmZrZTB2RGxEMTFjd013ZHFqdkp6dFRrMVp4eWxyejBfcnhsSWM2SVNmbEh0Yk1ub1BSZHN0V1NTRl9XUkxJRFExbS1tVGJFejdyMU5WOU1adw?oc=5","date":"2025-06-27","type":"pipeline","source":"businesswire.com","summary":"Metabolics Pharma Announces ENT-03 Generates Sustained Weight Loss and Liver Pathology Improvements in an Animal Model for Obesity - businesswire.com","headline":"Metabolics Pharma Announces ENT-03 Generates Sustained Weight Loss and Liver Pathology Improvements in an Animal Model f","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxObzVhTnBSMjViTFhxRk9SYlB2TExWc0RZNVJ5cDFQZW1KY2NtU2lhMUhYVndHZXU4NjBESS1zN0hRYks1bF9KTllBTkh0ZVY5NUNvVlFwVTZ2TXdRY3ZlTXlFRFNFYUV5R1pLLTFDWGhjR09TdWZyVnpXdXdiemR4cVNXeVZYUlNscUVFcVoyLXhMY0hNX2Fxb0s4S1ZnSE1GclBWandpVFFLTTFLSXBsLV9xVFFxU3F4LVRaUHhueER2WEpBN3A5Z3pNT180eEhpbTdFWmpSNA?oc=5","date":"2025-03-07","type":"pipeline","source":"PR Newswire","summary":"Orphalan becomes the first European company to enter in China's Wilson Disease market - PR Newswire","headline":"Orphalan becomes the first European company to enter in China's Wilson Disease market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxQdzNUZFRCTVhoSUllbW1XakkxWEZseVhpUVpUMldwNkhMSGZSR0EtYlFZdTREMG5hVUpPWDRwMEJfNW94eU1JbzdXeUVubkl5MnZtUFZLWTMzME9kbW9yTnFkVWdtQjJLRjVBdWtxeHMyTDh6Rk5peXNDaHUxSWthampFTVdfbVowNExVUmFvMnpOYjlsVGs1MmpLbHlvbW56RmlBOE5zVnZzY2VVYnlrU2dST0k5RmVGTU9GdVI5eDBDd1lURE1vU2tBV1ZuR1lwUzNwanBWS29uNW5qZVVaVGtvT1VkdXVkU2swQlQxQVgtNWVkdk95UEVJUVRycDAzNk9mSjl0b1RZaXV1cGxzSlg1bUE3Q3FTWmVLVFgzWW9YQ2M5amNaeQ?oc=5","date":"2025-02-13","type":"trial","source":"GlobeNewswire","summary":"Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel - GlobeNewswire","headline":"Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE5HSFVuNDZZZmxyM2dsQ2taUHoyNDFmaFlFMkVaZDd5cW5LR2x5RTFxYWdHZUZsREZjdTdSZEhiV3pPU0Jhd3NpMGhLclgtOUxtWG1obTZIR1RPTGs?oc=5","date":"2025-01-01","type":"pipeline","source":"Cure Parkinson's","summary":"The road ahead: 2025 (part 1) - Cure Parkinson's","headline":"The road ahead: 2025 (part 1) - Cure Parkinson's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNcmZzTFhRRzJnSWhnelMyNkJ0ZkdaalpDMDVEd3M4UDhSenotbGJkWTQ0S1NJaF9TS3hvMDY2RWMzT0F4QWxRaEMtSzhmZmI5N1E1a2tkM0VCTVJjVldyRE5RN0M5MmlFU29femtFek9yVnBxSy1TZ3p2Tk5qVnB5SFdFY3dkT3cwRXhTNE9DSkw5RGsyTkFJUHlMemFDOFlhQzNWR0xHSVJVNjRaMVdrZTJQNk1NYzc1SS1CbC00VWgwUWNBVDlaNERGX1p1dVBlQjlNT2hB?oc=5","date":"2024-01-18","type":"deal","source":"Proactive financial news","summary":"Willow Bioscience announces unique collaboration with Enterin Inc - Proactive financial news","headline":"Willow Bioscience announces unique collaboration with Enterin Inc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQNDc5b2ZsRHg2R2lQa19pZmpNQlRGQ1VSNlp5dFNCazNzUlFiMUVXRVExbmFUejlrZDNvNUdiLXY4eXdwb1lOaDVyVnQ2LWdVa3UxcjcxdktLbWU5WGxoTzdwbnNZb1NubHlqWFJ6VDhjYlNDRGxtQUt6OFcwcVpWX2s0akFqelFTQVYyWE5jNmc4Y3hFdDdRR19sR3QwWFdnQUFCeWsxcDlYWlk?oc=5","date":"2021-10-11","type":"pipeline","source":"The Business Journals","summary":"Enterin raises another $5.7 million to advance potential Parkinson's therapy - The Business Journals","headline":"Enterin raises another $5.7 million to advance potential Parkinson's therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOZGdBQ0ZPSEF1ZHd0c1Q2aVhDTnNyR1NKcnpOb0d5SEphZ25lQ2FTaDZvLVRJN1NGVWxIQ1E1WXdtcmxpX0JSZmxlY3JydW9KZ1Z6c0hJSUlMYUVjMm93NUpzdjAzUnJCMTRoMEp6OFUtTmFGa0Zzc3c3NHRmVHRCMzZybzhKclhidDJJWQ?oc=5","date":"2021-09-13","type":"pipeline","source":"Yahoo Finance","summary":"Enterin Announces Appointment of Dr. Roger Mills to Its Board of Directors - Yahoo Finance","headline":"Enterin Announces Appointment of Dr. Roger Mills to Its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPaUdtWHRiOGt6SC1ndUZTNVhDOUJBamZWeEZMX0JWRUV5VXFhd2RoNXc4NDFMNkhaRUQ5WlltRlVlY3dqTXpqS2UwQVlDY3hFbXFwVFphRkJCODZ2WUk4ekZMQkYtUVFWZU5YcDZFNmJFRm1QRTVnUzl1Qk1oUlAxMkVkeGVlZkljX2ZxVWltVVhaVjdJMUIyQWk0dDg?oc=5","date":"2020-10-16","type":"pipeline","source":"PR Newswire","summary":"Enterin Announces Appointment of New CEO - PR Newswire","headline":"Enterin Announces Appointment of New CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNQ1VLQ1MyczB3SUVVMFFxZmphNl9qY0R1ZGxjMy1NOGJQMzcyWWJjYWVnTE9CYzFqX2QyUjJCZ3VTdWxHTUhoekZBc3h5bTVZd01LaHVZX2lWdU9xdHFKc3Q0X19SQVpERUJ0T3pPWUN0LUlXNnZRc0hvaGZqaXlvWHJhaVRfNEE1bU9BeVJMYkNTeFZSNlhnSWlGS0kyVGZEVGFnQUU4Z0ZXNjFT?oc=5","date":"2020-09-18","type":"pipeline","source":"The Business Journals","summary":"Philadelphia biotech firm raises $14.2M to advance potential Parkinson's disease therapy - The Business Journals","headline":"Philadelphia biotech firm raises $14.2M to advance potential Parkinson's disease therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFBCNlFBRDFRbTN3Rkh2ZlFGRFJLN2hWTGowZU9BMHFrcl9Zb1prUkxqQUMzT01JbXNlN2wxWnBaUDVpZ0pRaVVXRnpiQWowRm1IekxlWVNSZXRnNzRqNVhpQXhieDllOExB?oc=5","date":"2019-08-29","type":"trial","source":"BioSpace","summary":"Enterin’s RASMET Study Published - BioSpace","headline":"Enterin’s RASMET Study Published","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPYU91b18yVzhpWVBkTzhsRmdUT0xPbHZrcUt6UVJGeENCLUZDMGFVbjdxQnptdWY4SGhuWGk1OTRCRnYtRVVSczBVRjQzVDBrbzNjZ2dnNi1aMWdGZU44NjlGTU1jeVoxWTVBdXZodF9ib0lyTHZiR2xYSktrdmR3akY2NnF1b29sTzhfaUt5NEdkeWgyQW1lZWZGTDdMT056NDZkc1RxcEpuM0NGZFN2VG1rcjJBdG8?oc=5","date":"2017-08-09","type":"pipeline","source":"Inquirer.com","summary":"An $872 million week for Philly biotech companies - Inquirer.com","headline":"An $872 million week for Philly biotech companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOT1oyRDhOdm13TDhpVDhoR1NiVWM1d3B4b0Nib2h0OWRBdnBfaXBCc2pzQkgxaXVHV1RiUWk5MTBUYW92bEdCbDVWbDV2N3pIQ2xIYWdVRkxkYTEtcmlfQ0RWWnUtU3NLOG5KMWFLYkc2bjg4V080SmdmT2NIUWhYdE40RGctWXM4OEIwcmN4bmw0azF4Wkx6dEZDMTFRVXJ1Vjl3?oc=5","date":"2017-07-17","type":"pipeline","source":"Fierce Biotech","summary":"Backers put $12.7M behind Enterin's Parkinson's disease approach - Fierce Biotech","headline":"Backers put $12.7M behind Enterin's Parkinson's disease approach","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}